COGT - Cogent Biosciences Inc
Cogent Biosciences Inc Logo

COGT - Cogent Biosciences Inc

https://www.cogentbio.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.

52W High
$13.50
52W Low
$3.72

MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.35
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-3.89
EV/Revenue (<3 favorable)
925.41
P/S (TTM) (<3 favorable)
1320.63
P/B (<3 favorable)
38.69
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.04%
Institutions (25–75% balanced)
105.48%
Shares Outstanding
139,701,000
Float
102,749,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
-121,627,000
EPS (TTM)
-2.08
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-1.08%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
0.4599
Previous
0.4937
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025